Peimisine
Peimisine can affect M-receptor, excit β-receptor, restrain the release of internal calcium, and promote to releaseing nitrogen monoxidum in order to relax tracheal smooth muscle and relieve asthma. Peimisine can attenuate lung tissue injury (ALI), LDH and MDA amount in ALI mice in a dose dependent manner, it also lower the total protein, total white blood cells, lymphocyte and neutrophilic leukocyte in bronchoalveolar lavage fluid (BALF) ; suggests that peimisine can play a protective role against LPS-induced acute lung injury. Peimisine has the protective effect on the experimental hepatic fibrosis formation, the possible mechanisms are associated with inhibiting fibrogenesis and fibrosis accumulation, and decreasing lipid peroxidation. Peimisine can inhibit angiotensin I converting enzyme activity in a dose-dependent manner, displaying 5 % inhibitory concentration values of 526.5 microM, thus, it may have antihypertensive action.
Product Specifications
CAS Number
19773-24-1
Product Name Alternative
Ebeiensine
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 12.5 mg/mL (29.23 mM)
Smiles
CC1CC2C (C (C3 (O2) CCC4C5CC (=O) C6CC (CCC6 (C5CC4=C3C) C) O) C) NC1
Molecular Formula
C27H41NO3
Molecular Weight
427.62
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog